• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICROVENTION, INC. MICROPLEX COMPLEX; EMOLIZATION COIL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICROVENTION, INC. MICROPLEX COMPLEX; EMOLIZATION COIL Back to Search Results
Model Number 100512CC-V-A
Medical Device Problem Codes Detachment Of Device Component (1104); Activation, Positioning or Separation Problem (2906)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/09/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This device is used for treatment, not diagnosis.The microplex coil system (mcs) is intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae.The mcs is also intended for vascular occlusion of blood vessels within the neurovascular system to permanently obstruct blood flow to an aneurysm or other vascular malformation and for arterial and venous embolizations in the peripheral vasculature.Per the instructions for use: potential complications include, but are not limited to: hematoma at the site of entry, vessel perforation, aneurysm rupture, parent artery occlusion, incomplete aneurysm filling, emboli, hemorrhage, ischemia, vasospasm, coil migration or misplacement, premature or difficult coil detachment, clot formation, revascularization, post-embolization syndrome, and neurological deficits including stroke and possibly death.Cases of chemical aseptic meningitis, edema, hydrocephalus and/or headaches have been associated with the use of embolization coils in the treatment of large and giant aneurysms.The physician should be aware of these complications and instruct patients when indicated.Appropriate patient management should be considered.This device involved in this event could not be evaluated as it was reported not available.The root cause cannot be determined or confirmed.(b)(4).
 
Event or Problem Description
The customer reported that during an embolization coiling treatment, resistance was encountered during coil positioning.The coil was reported to prematurely detached from the delivery pusher within the catheter.The coil and catheter were withdrawn together successfully.No harm or injury occured as a result of this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MICROPLEX COMPLEX
Common Device Name
EMOLIZATION COIL
Manufacturer (Section D)
MICROVENTION, INC.
1311 valencia ave
tustin CA 92780
MDR Report Key5490698
Report Number2032493-2016-00036
Device Sequence Number13712575
Product Code HCG
UDI-Device Identifier00811425025659
UDI-Public(01)00811425025659(11)151105(17)201105(10)151105V2
Combination Product (Y/N)N
Initial Reporter CountryCA
PMA/510(K) Number
K050954
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 02/10/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Expiration Date11/05/2020
Device Model Number100512CC-V-A
Device Lot Number151105V2
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/10/2016
Initial Report FDA Received Date03/09/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age49 YR
-
-